航运股马士基跌2.7%，领跌一众成分股。 明晟公司MSCI北欧国家指数跌0.5%，报357.23点，北欧医疗保健板块领跌。 ...

诺和诺德涨4.7%，领跑一众成分股。 明晟公司MSCI北欧国家指数涨0.6%，报358.57点，北欧医疗保健板块领跑。 ...

诺基亚周五收跌3.6%，在一众成分股里表现最差。 明晟公司MSCI北欧国家指数跌0.4%，连续三个交易日走低，报356.16点。 ...

Financial Data and Key Metrics Changes - The company aims for low double-digit growth in the index business, currently experiencing high single-digit growth [3][9] - Growth rates with hedge funds are at 22%, wealth managers at 16%, asset owners at 10%, and broker-dealers at 11% [6] - Active managers, the largest client segment, have seen growth rates decline to slightly below 7% due to outflows and fee pressure [7][8] Business Line Data and Key Metrics Changes - The index business has historically shown double-digit growth, with recent trends indicating a shift towards personalized systematic portfolios [10][12] - Custom indexes and additional content sets are opening new opportunities for growth, particularly in wealth management and trading communities [14][15] - Non-market cap, non-ETF assets have grown at 37% in the first quarter, compared to 16% for market cap mandates [45] Market Data and Key Metrics Changes - The company has captured 45% of flows into developed markets outside the U.S. and emerging market ETFs, totaling approximately $37 billion of the $42 billion in flows in the first quarter [25][26] - There is a noted shift in capital flows towards international investing, which is beneficial for the company [20][28] Company Strategy and Development Direction - The company is focused on expanding its index offerings, particularly in custom indexes, which are seen as a major growth driver [42][44] - The strategy includes enhancing product offerings and maintaining a long-term pricing philosophy that emphasizes value addition over aggressive price hikes [34][35] - The company is also positioning itself to benefit from the ongoing shift from active to passive management, while still supporting active managers with innovative solutions [72][75] Management's Comments on Operating Environment and Future Outlook - Management emphasizes the importance of confidence in the market for driving client buying behavior, particularly in relation to equity market stability [16][17] - There is cautious optimism regarding the recovery of international investing and the potential for increased sales as market conditions stabilize [19][20] - The company acknowledges the current challenges in the ESG space but remains committed to helping clients navigate these complexities [95][98] Other Important Information - The company has seen strong growth in its analytics business, driven by fixed income analytics and factor models [84][86] - The competitive landscape remains stable, with the company maintaining strong market share in institutional and retail markets, particularly in Europe [31][32] Q&A Session Summary Question: What are the key growth drivers for the index business? - The company highlighted the utility of its products and the expansion of licensing to more parts of client organizations as key growth drivers [12][13] Question: How does the strengthening equity market affect new sales? - Management noted that sustained momentum in equity markets generally supports client confidence and buying behavior, although it varies by region and client type [16][17] Question: What are the leading indicators for international investing? - Key indicators include a depreciating U.S. dollar, macroeconomic cycles, and valuation comparisons between U.S. and international markets [22][24] Question: How is the company positioned in the custom index market? - The company sees custom indexes as a significant growth opportunity, particularly as clients seek personalized investment strategies [42][44] Question: What is the impact of the shift from active to passive management? - The company remains agnostic to the shift, believing it can benefit from both active and passive strategies, with a focus on providing tools for both [72][75] Question: What is the company's strategy for fixed income? - The company has invested in fixed income analytics and is focusing on differentiated fixed income indexes, particularly in ESG and climate-related areas [79][81]

Zealand Pharma A/S涨10%，领跑一众成分股。 明晟公司MSCI北欧国家指数涨1.4%，创5月12日以来最大单日涨幅，报360.29点，北欧医疗保健板块领 跑。 ...

明晟公司MSCI北欧国家指数跌0.4%，报355.17点，北欧工业板块领跌，本周累计下跌0.62%。 殷拓EQT AB跌3.1%，在一众成分股里表现最差。 ...

It has been about a month since the last earnings report for MSCI (MSCI) . Shares have added about 5% in that time frame, underperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is MSCI due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.How Have Estimates Been Moving Since Then?It turns out, estima ...

明晟公司MSCI北欧国家指数跌1.7%，创4月9日（当天收跌4.0%）以来最差单日表现，报356.97点，北 欧工业板块领跌。 可再生能源公司维斯塔斯风力技术跌6.3%，领跌一众成分股。 ...

明晟公司MSCI北欧国家指数微幅上涨，报363.69点，北欧医疗保健板块领跑。 中枢神经系统障碍、心血管疾病、泌尿障碍等疗法供应商Orion Oyj赫尔辛基股价涨4.1%，领跑一众成 分股。 这家芬兰公司宣布，其合作伙伴MSD已经将Opevesostat临床开发项目扩大至包括（一系列）女性癌 症。 ...

美国总统特朗普政府取消关于"叫停Equinor在纽约附近海域的50亿美元项目"的命令。 沃旭能源涨14.5%，领跑一众成分股。 明晟公司MSCI北欧国家指数涨1.1%，报363.74点，北欧医疗保健板块领跑。 ...